• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathy.

作者信息

Taylor-Robinson S D, Sargentoni J, Marcus C D, Morgan M Y, Bryant D J

机构信息

Robert Steiner MR Unit, Royal Postgraduate Medical School, Hammersmith Hospital, London, UK.

出版信息

Metab Brain Dis. 1994 Dec;9(4):347-59. doi: 10.1007/BF02098881.

DOI:10.1007/BF02098881
PMID:7898401
Abstract

Regional variations in proton magnetic resonance spectroscopy (MRS) were assessed in 26 patients and 14 healthy volunteers using a two dimensional chemical shift imaging technique. Patients were classified as being neuropsychiatrically unimpaired, or as having subclinical or overt chronic hepatic encephalopathy (CHE). Peak area ratios of choline (Cho), glutamine and glutamate (Glx) and N-acetylaspartate (NAA) relative to creatine (Cr) were measured. Significant reductions in mean Cho/Cr and elevations in mean Glx/Cr were observed in the patient population, which correlated with the severity of CHE. There were significant regional variations in these metabolite ratios with the mean Cho/Cr lowest in the occipital cortex and the mean Glx/Cr highest in the basal ganglia. NAA/Cr remained relatively constant in all areas of the brain analysed. The regional variation in the metabolite ratios suggests that spectral information from more than one voxel may be useful in the assessment of patients with CHE.

摘要

相似文献

1
Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathy.
Metab Brain Dis. 1994 Dec;9(4):347-59. doi: 10.1007/BF02098881.
2
MR imaging and spectroscopy of the basal ganglia in chronic liver disease: correlation of T1-weighted contrast measurements with abnormalities in proton and phosphorus-31 MR spectra.慢性肝病基底节的磁共振成像与波谱分析:T1加权对比测量值与质子和磷-31磁共振波谱异常的相关性
Metab Brain Dis. 1996 Sep;11(3):249-68. doi: 10.1007/BF02237962.
3
In vivo 1H magnetic resonance spectroscopy-derived metabolite variations between acute-on-chronic liver failure and acute liver failure.基于体内1H磁共振波谱分析的慢性肝衰竭急性发作与急性肝衰竭之间代谢物的差异
Liver Int. 2008 Sep;28(8):1095-103. doi: 10.1111/j.1478-3231.2007.01648.x. Epub 2008 Feb 8.
4
1H-MR spectroscopy, magnetization transfer, and diffusion-weighted imaging in alcoholic and nonalcoholic patients with cirrhosis with hepatic encephalopathy.1H磁共振波谱、磁化传递和扩散加权成像在患有肝性脑病的酒精性和非酒精性肝硬化患者中的应用
AJNR Am J Neuroradiol. 2006 May;27(5):1019-26.
5
[Detection of subclinical and overt hepatic encephalopathy and treatment control after L-ornithine-L-aspartate medication by magnetic resonance spectroscopy ((1)H-MRS)].磁共振波谱法(¹H-MRS)检测L-鸟氨酸-L-天冬氨酸药物治疗后亚临床和显性肝性脑病及治疗控制情况
Z Gastroenterol. 2005 Apr;43(4):373-8. doi: 10.1055/s-2004-813917.
6
Viability assessment of magnetic resonance spectroscopy for the detection of minimal hepatic encephalopathy severity.磁共振波谱法检测轻微肝性脑病严重程度的可行性评估
Eur J Radiol. 2015 Oct;84(10):2019-23. doi: 10.1016/j.ejrad.2015.06.027. Epub 2015 Jun 30.
7
[Cerebral magnetic resonance spectroscopy in patients with hepatic encephalopathy: analysis before and after liver transplantation].肝性脑病患者的脑磁共振波谱分析:肝移植前后的分析
Rev Assoc Med Bras (1992). 2009 Jan-Feb;55(1):35-9. doi: 10.1590/s0104-42302009000100012.
8
Cerebral 1H MR spectroscopy and neuropsychologic status of patients with hepatic encephalopathy.肝性脑病患者的脑1H磁共振波谱分析与神经心理状态
AJR Am J Roentgenol. 1998 Oct;171(4):1123-30. doi: 10.2214/ajr.171.4.9763008.
9
Proton MR spectroscopic measurement of neurometabolites in hepatic encephalopathy during oral lactulose therapy.口服乳果糖治疗期间肝性脑病中神经代谢物的质子磁共振波谱测量
AJNR Am J Neuroradiol. 1998 Oct;19(9):1681-6.
10
MR imaging and (1)H spectroscopy of brain metabolites in hepatic encephalopathy: time-course of renormalization after liver transplantation.肝性脑病患者脑代谢物的磁共振成像及氢质子磁共振波谱分析:肝移植后恢复正常的时间进程
Radiology. 2000 Sep;216(3):683-91. doi: 10.1148/radiology.216.3.r00se27683.

引用本文的文献

1
Brain Edema in Chronic Hepatic Encephalopathy.慢性肝性脑病中的脑水肿
J Clin Exp Hepatol. 2019 May-Jun;9(3):362-382. doi: 10.1016/j.jceh.2019.02.003. Epub 2019 Feb 19.
2
Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis.专门针对氨用于预防和治疗肝硬化成年患者肝性脑病的药物疗法。
Cochrane Database Syst Rev. 2019 Jun 17;6(6):CD012334. doi: 10.1002/14651858.CD012334.pub2.
3
Neuroimaging in alcohol use disorder: From mouse to man.酒精使用障碍的神经影像学:从鼠到人。

本文引用的文献

1
Studies of the blood ammonia in liver disease. Its diagnostic, prognostic, and therapeutic significance.肝脏疾病血氨的研究。其诊断、预后及治疗意义。
Ann Intern Med. 1963 Jan;58:1-24. doi: 10.7326/0003-4819-58-1-1.
2
Effect of reducing brain glutamine synthesis on metabolic symptoms of hepatic encephalopathy.降低脑谷氨酰胺合成对肝性脑病代谢症状的影响。
J Neurochem. 1993 Mar;60(3):1000-6. doi: 10.1111/j.1471-4159.1993.tb03247.x.
3
Hyperintense globus pallidus on T1-weighted MRI in cirrhotic patients is associated with severity of liver failure.
J Neurosci Res. 2022 May;100(5):1140-1158. doi: 10.1002/jnr.24423. Epub 2019 Apr 22.
4
L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis.L-鸟氨酸L-天冬氨酸用于预防和治疗肝硬化患者的肝性脑病。
Cochrane Database Syst Rev. 2018 May 15;5(5):CD012410. doi: 10.1002/14651858.CD012410.pub2.
5
Alcohol's Effects on the Brain: Neuroimaging Results in Humans and Animal Models.酒精对大脑的影响:人类和动物模型的神经影像学结果
Alcohol Res. 2017;38(2):183-206.
6
Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathy.氟马西尼与安慰剂或不进行干预对肝硬化和肝性脑病患者的影响
Cochrane Database Syst Rev. 2017 Aug 10;8(8):CD002798. doi: 10.1002/14651858.CD002798.pub4.
7
Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathy.氟马西尼与安慰剂或不进行干预对肝硬化和肝性脑病患者的影响。
Cochrane Database Syst Rev. 2017 Jul 26;7(7):CD002798. doi: 10.1002/14651858.CD002798.pub3.
8
A longitudinal study of patients with cirrhosis treated with L-ornithine L-aspartate, examined with magnetization transfer, diffusion-weighted imaging and magnetic resonance spectroscopy.一项对接受L-鸟氨酸L-天冬氨酸治疗的肝硬化患者进行的纵向研究,采用磁化传递、扩散加权成像和磁共振波谱进行检查。
Metab Brain Dis. 2017 Feb;32(1):77-86. doi: 10.1007/s11011-016-9881-3. Epub 2016 Aug 3.
9
Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.不可吸收双糖与安慰剂/无干预措施的比较以及乳果糖与乳糖醇在肝硬化患者肝性脑病预防和治疗中的比较。
Cochrane Database Syst Rev. 2016 May 6;2016(5):CD003044. doi: 10.1002/14651858.CD003044.pub4.
10
Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015.丙型肝炎病毒相关的神经认知和神经精神障碍:2015年的进展
World J Gastroenterol. 2015 Nov 14;21(42):11974-83. doi: 10.3748/wjg.v21.i42.11974.
肝硬化患者T1加权磁共振成像上苍白球高信号与肝衰竭严重程度相关。
Neurology. 1993 Jan;43(1):65-9. doi: 10.1212/wnl.43.1_part_1.65.
4
Glutamate in Huntington's disease.
Lancet. 1994 Jul 16;344(8916):189-90. doi: 10.1016/s0140-6736(94)92788-x.
5
Evidence for glutamate excitotoxicity in Huntington's disease with proton magnetic resonance spectroscopy.利用质子磁共振波谱法研究亨廷顿舞蹈病中谷氨酸兴奋性毒性的证据。
Lancet. 1994 May 7;343(8906):1170. doi: 10.1016/s0140-6736(94)90280-1.
6
Successful use of bromocriptine in the treatment of chronic hepatic encephalopathy.溴隐亭成功用于慢性肝性脑病的治疗。
Gastroenterology. 1980 Apr;78(4):663-70.
7
Synergism between mercaptans and ammonia or fatty acids in the production of coma: a possible role for mercaptans in the pathogenesis of hepatic coma.硫醇与氨或脂肪酸在昏迷产生中的协同作用:硫醇在肝昏迷发病机制中的可能作用。
J Lab Clin Med. 1974 Jan;83(1):16-28.
8
Transection of the oesophagus for bleeding oesophageal varices.为治疗食管静脉曲张出血而行食管横断术。
Br J Surg. 1973 Aug;60(8):646-9. doi: 10.1002/bjs.1800600817.
9
Changes in brain metabolism in hepatic encephalopathy.
Neurochem Pathol. 1987 Feb-Apr;6(1-2):35-66. doi: 10.1007/BF02833600.
10
The role of astrocytes in hepatic encephalopathy.星形胶质细胞在肝性脑病中的作用。
Neurochem Pathol. 1987 Feb-Apr;6(1-2):13-33. doi: 10.1007/BF02833599.